Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid Induced Skin Atrophy Assessment by Sonography
NCT02355639Phase 1Completed
- Sponsor
- LEO Pharma
- Start
- Jan 2015
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of betamethasone dipropionate spray 0.05% and clobetasol in psoriasis and Eczema (3 arms), sponsored by LEO Pharma. Primary endpoint: Change in skin thickness from baseline to end of treatment at 4 weeks. Started Jan 2015; status: completed.
02
Drugs
betamethasone dipropionate spray 0.05%clobetasol
03
Conditions
psoriasisEczema
Beyond the preview
Go deeper on NCT02355639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02355639.